Skip to content

R&D at other companies

Merck & Co. logo
Merck & Co.MRK
$12.59B+248%
Neogen logo
NeogenNEOG
$3.8M-15.6%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$65.79M+11.4%
Revvity logo
RevvityRVTY
$57.89M+8.0%
Scilex Holding Company logo
Scilex Holding CompanySCLX
$3.21M+30.7%
Agilent Technologies logo
Agilent TechnologiesA
$126M+12.5%

Other financials

Income statement

See full
Revenue$2.3B+2.9%
Gross profit$1.6B+2.6%
Net income$601.0M-0.2%
EPS (diluted)$1.42+6.0%

Balance sheet

See full
Cash & equivalents$1.9B+8.9%
Total debt$10.0B+48.0%
Total equity$3.2B-30.5%
Total assets$15.2B+7.5%

Cash flow

See full
Operating cash flow$401.0M-22.1%
CapEx$110.0M-38.2%
Free cash flow$291.0M-13.6%

Valuation

See full
Market cap$30.13B-56.6%
Enterprise value$38.17B-48.9%
P/E11.4×-15.5×
P/S3.2×-4.2×

Profitability

See full
Gross margin71.8%+0.8pp
Net margin27.8%+0.9pp
FCF margin23.5%0.0pp

Returns & leverage

See full
Return on equity67%+15.8pp
Debt / equity3.1×+1.6×
Current ratio3.2×+1.4×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zoetis's R&D?
Zoetis (ZTS) reported R&D of $180M in Q1 2026.
How has Zoetis's R&D changed year-over-year?
Zoetis's R&D increased by 11.1% year-over-year, from $162M to $180M.
What is the long-term trend for Zoetis's R&D?
Over 4 years (2021 to 2025), Zoetis's R&D has grown at a 8.5% compound annual growth rate (CAGR), from $508M to $703M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.